|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2002-6-11
|
|
pubmed:abstractText |
Reports of vitiligo associated with metastases and rare cases of spontaneous regression of disease have fueled enthusiasm for immunologic approaches to the treatment of advanced melanoma. More recent strategies have focused on using antigen-presenting dendritic cells as vaccines.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Cancer Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/MART-1 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/MLANA protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/SILV protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/gp100 Melanoma Antigen
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0003-987X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
138
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
799-802
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12056962-Adenoviridae,
pubmed-meshheading:12056962-Adult,
pubmed-meshheading:12056962-Aged,
pubmed-meshheading:12056962-Antigens, Neoplasm,
pubmed-meshheading:12056962-Biopsy, Needle,
pubmed-meshheading:12056962-Cancer Vaccines,
pubmed-meshheading:12056962-Female,
pubmed-meshheading:12056962-Follow-Up Studies,
pubmed-meshheading:12056962-Humans,
pubmed-meshheading:12056962-Hypopigmentation,
pubmed-meshheading:12056962-MART-1 Antigen,
pubmed-meshheading:12056962-Male,
pubmed-meshheading:12056962-Melanoma,
pubmed-meshheading:12056962-Membrane Glycoproteins,
pubmed-meshheading:12056962-Neoplasm Proteins,
pubmed-meshheading:12056962-Neoplasm Staging,
pubmed-meshheading:12056962-Risk Assessment,
pubmed-meshheading:12056962-Skin Neoplasms,
pubmed-meshheading:12056962-gp100 Melanoma Antigen
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Hypopigmentation associated with an adenovirus-mediated gp100/MART-1-transduced dendritic cell vaccine for metastatic melanoma.
|
|
pubmed:affiliation |
Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114, USA. htsao@partners.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
